New Delhi: Zydus Lifesciences and Perfect Day Inc, a Temasek portfolio company, have signed an agreement to buy the latter’s 50% stake in Sterling Biotech in a Rs 550 crore deal. Post the transaction, Sterling Biotech will become a 50:50 joint venture, a company statement said. Sterling Biotech is one of the leading producers of pharmaceutical Gelatine, Di-Calcium Phosphate and some APIs.
Read More…
Zydus to buy 50% stake in Sterling Biotech | India News
